Search

Displaying results 7701 - 7710 of 8970 in total
  1. Drug

    Gantacurium

    go.drugbank.com/drugs/DB05710
    Investigational

    It is being developed by Avera Pharmaceuticals.

  2. Drug

    Amenamevir

    go.drugbank.com/drugs/DB11701
    Investigational

    Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  3. Drug

    Hygromycin B

    go.drugbank.com/drugs/DB11520
    ExperimentalVet approved

    Hygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis.

  4. Drug

    TG-C

    go.drugbank.com/drugs/DB06004
    Investigational

    Synonyms: TG-C
  5. Drug

    Calcium silicate

    go.drugbank.com/drugs/DB13829
    Investigational

    Categories: Drugs for Acid Related Disorders
  6. Drug

    Aconiazide

    go.drugbank.com/drugs/DB17731
    Experimental

    Synonyms: Isonicotinic acid (o-(carboxymethoxy)benzylidene)hydrazideCategories: Drugs for Treatment of Tuberculosis
  7. Drug

    Romifidine

    go.drugbank.com/drugs/DB11543
    ExperimentalVet approved

    This drug's chemical structure closely resembles that of clonidine, however, romifidine is not approved for use in humans.

  8. Drug

    QazCovid-in

    go.drugbank.com/drugs/DB16441
    Investigational

    The QazCovid-in vaccine, an inactivated vaccine, was developed and tested in the Kazakh Research Institute for Biological Safety Problems[L30628].

  9. Drug

    Serabelisib

    go.drugbank.com/drugs/DB14935
    Investigational

    Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics

  10. Drug

    Macozinone

    go.drugbank.com/drugs/DB14821
    Investigational

    Macozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169).

    Categories: Drugs for Treatment of Tuberculosis